Upgrade to SI Premium - Free Trial

Depomed (DEPO) Will File Revocation Statement with U.S. SEC Tied to Horizon Pharma (HZNP) Offer

August 10, 2015 6:12 AM
Depomed (Nasdaq: DEPO) intends to file a revocation statement and revocation card with the U.S. Securities and Exchange Commission (the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Mergers and Acquisitions

Next Articles